So, guys, Derek, more plates, more dates.com. Today we're going to be talking about

Osterine, also known as MK2866 and Inobosar. So we're going to be going over everything

there is to know about it, complete overview, top to bottom. Osterine is the most well known and

extensively studied selective endogen receptor modulator right now.

It's categorized as a SARM because of its unique selectivity at the androgen receptor where it exhibits a significant amount of

anabolic activity in the body relative to endogenic activity.

So it's being researched to determine if it's a potential treatment for the management

of muscle and bone wasting diseases.

Basically, I'm going to talk somewhat briefly.

It's going to be pretty elaborate, actually, about its potential therapeutic applications,

side effects, anecdotal findings based on my own personal research,

et cetera. So what is it exactly? It's also known as the Nobosarm, GTX-024, and MK2866. So

SARM and SARMs like Austerine stimulate androgen receptors in a selective way,

whereby they induce a significantly greater amount of anabolic activity in the body

relative to the endogenic activity.

So that's sort of where, you know, you define something as a SARM as its selective action

at the endergen receptor and the way it activates it and you know induces and

transcribes its effects. Testosterone was just to give it a bit of

background on you know the conception of SARMs. Testosterone was the first

anabolic androgen to be approved for use in a clinical setting. However,

its scope of versatility has always been

severely limited by its endrogenicity and its pharmacokinetic issues. So most notable being its

...